Cargando…
Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications
Comorbid diabetes mellitus (DM) increases tuberculosis (TB) risk and adverse outcomes but the pathological interactions between DM and TB remain incompletely understood. We performed an integrative analysis of whole blood gene expression and plasma analytes, comparing South Indian TB patients with a...
Autores principales: | Prada-Medina, Cesar A., Fukutani, Kiyoshi F., Pavan Kumar, Nathella, Gil-Santana, Leonardo, Babu, Subash, Lichtenstein, Flávio, West, Kim, Sivakumar, Shanmugam, Menon, Pradeep A., Viswanathan, Vijay, Andrade, Bruno B., Nakaya, Helder I., Kornfeld, Hardy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435727/ https://www.ncbi.nlm.nih.gov/pubmed/28515464 http://dx.doi.org/10.1038/s41598-017-01767-4 |
Ejemplares similares
-
Heightened circulating levels of antimicrobial peptides in tuberculosis—Diabetes co-morbidity and reversal upon treatment
por: Kumar, Nathella Pavan, et al.
Publicado: (2017) -
Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity
por: Kumar, Nathella Pavan, et al.
Publicado: (2021) -
Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity
por: Kumar, Nathella Pavan, et al.
Publicado: (2019) -
Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
por: Kumar, Nathella P., et al.
Publicado: (2018) -
Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden
por: Pavan Kumar, Nathella, et al.
Publicado: (2019)